|
1
|
Chen L, Magliano DJ and Zimmet PZ: The
worldwide epidemiology of type 2 diabetes mellitus-present and
future perspectives. Nat Rev Endocrinol. 8:228–236. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poitout DV and Robertson RP: An integrated
view of beta-cell dysfunction in type-II diabetes. Annu Rev Med.
47:69–83. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahrén B: Type 2 diabetes, insulin
secretion and beta-cell mass. Curr Mol Med. 5:275–286. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karaskov E, Scott C, Zhang L, Teodoro T,
Ravazzola M and Volchuk A: Chronic palmitate but not oleate
exposure induces endoplasmic reticulum stress, which may contribute
to INS-1 pancreatic beta-cell apoptosis. Endocrinology.
147:3398–3407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: Beta-cell deficit and increased
beta-cell apoptosis in humans with type 2 diabetes. Diabetes.
52:102–110. 2003. View Article : Google Scholar
|
|
6
|
Donath MY and Halban PA: Decreased
beta-cell mass in diabetes: Significance, mechanisms and
therapeutic implications. Diabetologia. 47:581–589. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rhodes CJ: Type 2 diabetes-a matter of
beta-cell life and death? Science. 307:380–384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayashi M, Kikuchi O, Sasaki T, Kim HJ,
Yokota-Hashimoto H, Lee YS, Amano K, Kitazumi T, Susanti VY,
Kitamura YI and Kitamura T: FoxO1 as a double-edged sword in the
pancreas: Analysis of pancreas- and β-cell-specific FoxO1 knockout
mice. Am J Physiol Endocrinol Metab. 302:E603–E613. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitamura YI, Kitamura T, Kruse JP, Raum
JC, Stein R, Gu W and Accili D: FoxO1 protects against pancreatic
beta cell failure through NeuroD and MafA induction. Cell Metab.
2:153–163. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kitamura T, Nakae J, Kitamura Y, Kido Y,
Biggs WH III, Wright CV, White MF, Arden KC and Accili D: The
forkhead transcription factor Foxo1 links insulin signaling to Pdx1
regulation of pancreatic beta cell growth. J Clin Invest.
110:1839–1847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Buteau J, Spatz ML and Accili D:
Transcription factor FoxO1 mediates glucagon-like peptide-1 effects
on pancreatic beta-cell mass. Diabetes. 55:1190–1196. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martinez SC, Tanabe K, Cras-Méneur C,
Abumrad NA, Bernal-Mizrachi E and Permutt MA: Inhibition of Foxo1
protects pancreatic islet beta-cells against fatty acid and
endoplasmic reticulum stress-induced apoptosis. Diabetes.
57:846–859. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kristiansen G, Pilarsky C, Pervan J,
Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A and
Dietel M: CD24 expression is a significant predictor of PSA relapse
and poor prognosis in low grade or organ confined prostate cancer.
Prostate. 58:183–192. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kristiansen G, Schlüns K, Yongwei Y,
Denkert C, Dietel M and Petersen I: CD24 is an independent
prognostic marker of survival in nonsmall cell lung cancer
patients. Br J Cancer. 88:231–236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu W and Vadgama JV: Identification and
characterization of amino acid starvation-induced CD24 gene in
MCF-7 human breast cancer cells. Int J Oncol. 16:1049–1103.
2000.PubMed/NCBI
|
|
16
|
Welsh JB, Zarrinkar PP, Sapinoso LM, Kern
SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA and Hampton GM:
Analysis of gene expression profiles in normal and neoplastic
ovarian tissue samples identifies candidate molecular markers of
epithelial ovarian cancer. Proc Natl Acad Sci USA. 98:1176–1181.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clark JD, Gebhart GF, Gonder JC, Keeling
ME and Kohn DF: The 1996 guide for the care and use of laboratory
animals. ILAR J. 38:41–48. 1997. View Article : Google Scholar
|
|
18
|
Dong W, Ding X, Cai J, Peng Y, Wang Y and
Tan J: Study on the standardization of islet isolation method in
rats. Chin J Cell Stem Cell (Electronic Edition). 2:237–240.
2012.In Chinese.
|
|
19
|
Pei Z, Zhu G, Huo X, Gao L, Liao S, He J,
Long Y, Yi H, Xiao S, Yi W, et al: CD24 promotes the proliferation
and inhibits the apoptosis of cervical cancer cells in vitro. Oncol
Rep. Dec 24–2015.Epub ahead of print. View Article : Google Scholar
|
|
20
|
Krenn PW, Hofbauer SW, Pucher S, Hutterer
E, Hinterseer E, Denk U, Asslaber D, Ganghammer S, Sternberg C,
Neureiter D, et al: ILK induction in lymphoid organs by a
TNFα-NF-κB-regulated pathway promotes the development of chronic
lymphocytic leukemia. Cancer Res. Feb 2–2015.Epub ahead of
print.
|
|
21
|
Sahu RP: Expression of the
platelet-activating factor receptor enhances benzyl
isothiocyanate-induced apoptosis in murine and human melanoma
cells. Mol Med Rep. 12:394–400. 2015.PubMed/NCBI
|
|
22
|
Woo IS, Jin H, Kang ES, Kim HJ, Lee JH,
Chang KC, Park JY, Choi WS and Seo HG: TMEM14A inhibits
N-(4-hydroxyphenyl) retinamide-induced apoptosis through the
stabilization of mitochondrial membrane potential. Cancer Lett.
309:190–198. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren F, Wang DB, Li T, Chen YH and Li Y:
Identification of differentially methylated genes in the malignant
transformation of ovarian endometriosis. J Ovarian Res. Jul
10–2014.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acac Sci USA. 102:15545–15550. 2005. View Article : Google Scholar
|
|
26
|
Guariguata L, Whiting DR, Hambleton I,
Beagley J, Linnenkamp U and Shaw JE: Global estimates of diabetes
prevalence for 2013 and projections for 2035. Diabetes Res Clin
Pract. 103:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu DA, Yoon J, Ko YS, Park J, Kim SY, Kim
MA, Kim JH, Jung J, Cheon Y, Lee HS, et al: Forkhead transcription
factor FOXO1 inhibits nuclear factor-κB in gastric cancer. APMIS.
122:848–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chick WL, Warren S, Chute RN, Like AA,
Lauris V and Kitchen KC: A transplantable insulinoma in the rat.
Proc Natl Acad Sci. 74:628–632. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Buteau J and Accili D: Regulation of
pancreatic Beta-cell function by the forkhead protein FoxO1.
Diabetes Obes Metab. 9(Suppl 2): S140–S146. 2007. View Article : Google Scholar
|
|
30
|
Ahlgren U, Jonsson J, Jonsson L, Simu K
and Edlund H: Beta-cell-specific inactivation of the mouseIpf1/Pdx1
gene results in loss of the beta-cell phenotype and maturity onset
diabetes. Genes Dev. 12:1763–1768. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jonsson J, Carlsson L, Edlund T and Edlund
H: Insulin-promoter-factor 1 is required for pancreas development
in mice. Nature. 371:606–609. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McLoughlin TJ, Smith SM, DeLong AD, Wang
H, Unterman TG and Esser KA: FoxO1 induces apoptosis in skeletal
myotubes in a DNA-binding-dependent manner. Am J Physiol Cell
Physiol. 297:C548–555. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi D, Lee HW, Hur KY, Kim JJ, Park GS,
Jang SH, Song YS, Jang KS and Paik SS: Cancer stem cell markers
CD133 and CD24 correlate with invasiveness and differentiation in
colorectal adenocarcinoma. World J Gastroenterol. 15:2258–2264.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Andersson SA, Olsson AH, Esguerra JL,
Heimann E, Ladenvall C, Edlund A, Salehi A, Taneera J, Degerman E,
Groop L, et al: Reduced insulin secretion correlates with decreased
expression of exocytotic genes in pancreatic islets from patients
with type 2 diabetes. Mol Cell Endocrinol. 364:36–45. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eliasson L, Abdulkader F, Braun M,
Galvanovskis J, Hoppa MB and Rorsman P: Novel aspects of the
molecular mechanisms controlling insulin secretion. J Physiol.
586:3313–3324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ammälä C, Eliasson L, Bokvist K, Larsson
O, Ashcroft FM and Rorsman P: Exocytosis elicited by action
potentials and voltage-clamp calcium currents in individual mouse
pancreatic B-cells. J Physiol. 472:665–688. 1993. View Article : Google Scholar : PubMed/NCBI
|
